70 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
are elected;
To ratify the appointment, by the Audit Committee of the Company’s Board of Directors, of Ernst & Young LLP, as the independent registered public … OF AUTHORIZED SHARES OF VOTING COMMON STOCK FROM 300,000,000 TO 500,000,000
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
CORPORATE GOVERNANCE
424B3
ALGS
Aligos Therapeutics Inc
28 Nov 23
Prospectus supplement
4:01pm
, that are not deemed “filed” with the SEC, including any Compensation Committee report, Audit Committee report, performance graph or any information
8-K
EX-10.1
guxgb27g f65pms
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
cfudk71o
25 Jul 23
Submission of Matters to a Vote of Security Holders
4:02pm
DEFA14A
5fy2 1imfzil7z
28 Apr 23
Additional proxy soliciting materials
4:55pm